Revolutionary technologies for developing customized stem cells on demand changes the end game for curative processes in medical industry. High competition in the market fueled by innovation keep the industry players motivated to invest strongly on R&D. Out of the several products, namely human, adult, induced pluripotent, rat neural, and embryonic stem cells, adult stem cells in specific dominate the market shares. Government aids clinical trials in some geographies attracts medical tourists seeking care. Rise of stem cell banks have also encouraged the reliability of stem cells to be used as a medical facility when required. Paying heed to the global market trends in the stem cells market, Big Market Research has added comprehensive reports focusing on the key drivers of demand, the technical and regulatory limitations as well as forthcoming opportunities for clinical researchers. Joint-ventures and mergers around the globe by industry giants have been mapped taking note of their operational verticals and respective financial performance over recent years.
No of Reports 0